RLAY Financials
Relay Therapeutics Inc - Financial statements & key metrics
Stock Price
$18.22
Market Cap
$3.39B
P/E Ratio
-7.7
EPS
$-1.72
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$10.01M
Gross Profit
-
Operating Income
-
Net Income
$-337.71M
EPS (Diluted)
$-2.36
Balance Sheet Highlights
Total Assets
$871.30M
Total Liabilities
$93.50M
Shareholders Equity
-
Cash & Equivalents
$124.29M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-249.11M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-3887.3%
ROE
-41.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is RLAY revenue?
RLAY's most recent quarterly revenue was $10.01M. Annual revenue can be calculated by summing the four most recent quarters.
Is RLAY profitable?
RLAY reported a loss of $337.71M in the most recent quarter.
What is RLAY market cap?
RLAY has a market capitalization of $3.39B, making it a mid-cap stock.
Does RLAY have debt?
View RLAY's balance sheet for debt information.
What is RLAY cash flow?
Cash flow data is available in the full financial statements.